A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT06417008 · RECRUITING
Trial details
- NCT number
- NCT06417008
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2026-06-01
- Enrollment
- 1080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.